Patents by Inventor Rafael Crabbe

Rafael Crabbe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160235808
    Abstract: The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus infection.
    Type: Application
    Filed: April 28, 2016
    Publication date: August 18, 2016
    Inventors: Claudio Avila, Rafael Crabbe
  • Publication number: 20150104415
    Abstract: The invention concerns the use of cyclophilin inhibitors in the treatment of Hepatitis C virus infection.
    Type: Application
    Filed: April 11, 2012
    Publication date: April 16, 2015
    Applicants: DEBIOPHARM INTERNATIONAL SA, NOVARTIS AG
    Inventors: Claudio Avila, Rafael Crabbe
  • Patent number: 8450281
    Abstract: The present invention relates to the use of a nonimmunosuppressive cyclosporin A derivative for reducing mitochondrial dysfunction and the rate of apoptosis of muscle cells of patients diagnosed with Ullrich congenital muscular dystrophy or Bethlem myopathy.
    Type: Grant
    Filed: January 3, 2008
    Date of Patent: May 28, 2013
    Assignee: Debiopharm S.A.
    Inventors: Paolo Bernardi, Gregoire Vuagniaux, Rafael Crabbe
  • Publication number: 20100041593
    Abstract: The present invention relates to the use of a nonimmunosuppressive cyclosporin A derivative for reducing mitochondrial dysfunction and the rate of apoptosis of muscle cells of patients diagnosed with Ullrich congenital muscular dystrophy or Bethlem myopathy.
    Type: Application
    Filed: January 3, 2008
    Publication date: February 18, 2010
    Inventors: Paolo Bernardi, Gregoire Vuagniaux, Rafael Crabbe